SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-227647
Filing Date
2023-09-01
Accepted
2023-09-01 16:12:00
Documents
17
Period of Report
2023-09-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d548812d8k.htm   iXBRL 8-K 29738
2 EX-1.1 d548812dex11.htm EX-1.1 176068
3 EX-5.1 d548812dex51.htm EX-5.1 7091
7 GRAPHIC g548812g0830034115174.jpg GRAPHIC 1499
8 GRAPHIC g548812g0830034115288.jpg GRAPHIC 5930
9 GRAPHIC g548812g0830034115399.jpg GRAPHIC 4525
  Complete submission text file 0001193125-23-227647.txt   401644

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20230901.xsd EX-101.SCH 2844
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20230901_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20230901_pre.xml EX-101.PRE 10808
11 EXTRACTED XBRL INSTANCE DOCUMENT d548812d8k_htm.xml XML 3227
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 231232650
SIC: 2836 Biological Products, (No Diagnostic Substances)